Cumberland Pharmaceuticals Inc (CPIX)

Currency in USD
5.840
-0.460(-7.30%)
Closed·
5.741-0.099(-1.70%)
·
High dividend Yield
CPIX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
5.7406.440
52 wk Range
2.0009.280
Key Statistics
Prev. Close
5.84
Open
6.3
Day's Range
5.74-6.44
52 wk Range
2-9.28
Volume
124.65K
Average Volume (3m)
113.6K
1-Year Change
194.2065%
Book Value / Share
4.84
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CPIX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Pays a significant dividend to shareholders
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Cumberland Pharmaceuticals Inc Earnings Call Summary for Q3/2026

  • Cumberland reported Q3 2026 EPS of $5.07 on revenue of $2.16M, driven by a one-time $108M gain from selling commercial assets to Apotex Health.
  • Cash surged to $80.6M from $11.4M at year-end 2025; company retired all debt and expects current cash to fund operations for over five years.
  • Paid $1.50/share special dividend totaling $22M; initiated share repurchase program as part of capital allocation strategy post-transaction.
  • Lead drug ifetroban for Duchenne muscular dystrophy cardiomyopathy advancing toward NDA submission following positive FIGHT DMD trial results.
  • Strategic pivot complete: company now focused on rare disease drug development rather than commercial operations, with pipeline progress key metric going forward.
Last Updated: 10/11/2026, 23:34
Read Full Transcript

Earnings

Latest Release
Nov 10, 2026
EPS / Forecast
5.07 / --
Revenue / Forecast
2.16M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -0.11
Dividend Yield
25.68%
Industry Median 2.10%
Annualised payout
1.50
Paid unevenly
5-Years Growth
-
Growth Streak

CPIX Income Statement

Compare CPIX to Peers and Sector

Metrics to compare
CPIX
Peers
Sector
Relationship
P/E Ratio
−52.9x−1.4x−0.2x
PEG Ratio
−0.02−0.050.00
Price/Book
1.2x1.8x2.6x
Price / LTM Sales
1.9x1.4x2.6x
Upside (Analyst Target)
-201.2%77.0%
Fair Value Upside
Unlock−0.8%13.7%Unlock

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Sancuso, a transdermal patch for the prevention of nausea and vomiting in patients receiving chemotherapy treatment; Vaprisol, an injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Vibativ, an injection for the treatment of certain bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections; and Tacilia, an oral capsule for the treatment of H. pylori infection. It also develops ifetroban, a product candidate that has completed Phase II clinical trials for the treatment of cardiomyopathy associated with Duchenne muscular dystrophy, hepatorenal syndrome, portal hypertension, aspirin-exacerbated respiratory disease, systemic sclerosis, and idiopathic pulmonary fibrosis. It serves hospital acute care, gastroenterology, and oncology markets in the United States, China, South Korea, Russia, Mexico, Australia, and Saudi Arabia. The company has a strategic alliance agreement with WinHealth Pharma Group Co. Limited. Cumberland Pharmaceuticals Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee.

Employees
93

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
752.88K5.02%4.40M
Other Institutional Investors
3.03M20.22%17.71M
Public Companies & Retail Investors
11.21M74.76%65.45M
Total
14.99M100.00%87.56M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Diversified Trust Company, Inc.4.67%700,0004,088
Integrated Core Strategies (US) LLC3.99%598,6343,496

People Also Watch

460.54
LITE
-13.94%
39.51
CRWV
-12.02%
99.53
GDDY
-2.56%
204.78
TER
-9.96%
261.11
WDC
-12.02%

FAQ

What Is the Cumberland (CPIX) Stock Price Today?

The Cumberland stock price today is 5.840 USD.

What Stock Exchange Does Cumberland Trade On?

Cumberland is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Cumberland?

The stock symbol for Cumberland is "CPIX."

What Is the Cumberland (CPIX) Afterhours Price Today? (Afterhours variable test: 5.741) Current Date: Nov 22, 2026

After hours price: 5.741. After hours price change (units): -0.099. Price change percentage: -1.700%

What Is the Cumberland Market Cap?

As of today, Cumberland market cap is 87.570M USD.

What Is Cumberland's Earnings Per Share (TTM)?

The Cumberland EPS (TTM) is -0.11.

From a Technical Analysis Perspective, Is CPIX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Cumberland Stock Split?

Cumberland has split 0 times.

How Many Employees Does Cumberland Have?

Cumberland has 93 employees.

What is the current trading status of Cumberland (CPIX)?

As of Nov 22, 2026, Cumberland (CPIX) is trading at a price of 5.840 USD, with a previous close of 5.840 USD. The stock has fluctuated within a day range of 5.740 USD to 6.440 USD, while its 52-week range spans from 2.000 USD to 9.280 USD.

What Is the CPIX Premarket Price?

CPIX's last pre-market stock price is 6.550 USD. The pre-market share volume is 13,350.000, and the stock has decreased by 0.250, or 3.970%.

What Is the CPIX After Hours Price?

CPIX's last after hours stock price is 5.741 USD, the stock has decreased by -0.099, or -1.700%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.